Ezrin dephosphorylation/downregulation contributes to ursolic acid-mediated cell death in human leukemia cells

Blood Cancer Journal

Volumn 3, Issue 4, 2013, Pages

  Li, G ^a   Zhou, T ^a   Liu, L ^a   Chen, J ^a   Zhao, Z ^a   Peng, Y ^b   Li, P ^b   Gao, N ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b China Pharmaceutical University   (China)

Author keywords

AML; Apoptosis; DISC formation; Ezrin; Rho ROCK1 signaling; Ursolic acid

Indexed keywords

CYTOSKELETON PROTEIN; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; EZRIN; FAS ANTIGEN; URSOLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LETHALITY; LEUKEMIA CELL; MOUSE; MURINE LEUKEMIA; NONHUMAN; PROTEIN DEPHOSPHORYLATION; RECEPTOR DOWN REGULATION;

EID: 84878298628     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2013.7     Document Type: Article

References (42)

1. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995; 49: 57-68.
2. Lee HZ, Bau DT, Kuo CL, Tsai RY, Chen YC, Chang YH. Clarification of the phenotypic characteristics and anti-tumor activity of Hedyotis diffusa. Am J Chin Med 2011; 39: 201-213.
3. Lin CC, Kuo CL, Lee MH, Hsu SC, Huang AC, Tang NY et al. Extract of Hedyotis diffusa Willd influences murine leukemia WEHI-3 cells in vivo as well as promoting T-and B-cell proliferation in leukemic mice. In Vivo 2011; 25: 633-640.
4. Gao N, Cheng S, Budhraja A, Gao Z, Chen J, Liu EH et al. Ursolic acid induces apoptosis in human leukaemia cells and exhibits anti-leukaemic activity in nude mice through the PKB pathway. Br J Pharmacol 2012; 165: 1813-1826.
5. Kuttan G, Pratheeshkumar P, Manu KA, Kuttan R. Inhibition of tumor progression by naturally occurring terpenoids. Pharm Biol 2011; 49: 995-1007.
6. Zhang T, He YM, Wang JS, Shen J, Xing YY, Xi T. Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPbeta expression by ERK pathway activation. Anticancer Drugs 2011; 22: 158-165.
7. Liu XS, Jiang J. Induction of apoptosis and regulation of the MAPK pathway by ursolic acid in human leukemia K562 cells. Planta Med 2007; 73: 1192-1194.
8. Baek JH, Lee YS, Kang CM, Kim JA, Kwon KS, Son HC et al. Intracellular Ca2 release mediates ursolic acid-induced apoptosis in human leukemic HL-60 cells. Int J Cancer 1997; 73: 725-728.
9. Hsu HY, Yang JJ, Lin CC. Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 1997; 111: 7-13.
10. Sultana N. Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J Enzyme Inhib Med Chem 2011; 26: 616-642.
11. Sato N, Funayama N, Nagafuchi A, Yonemura S, Tsukita S. A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites. J Cell Sci 1992; 103: 131-143.
12. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998; 140: 647-657.
13. Akisawa N, Nishimori I, Iwamura T, Onishi S, Hollingsworth MA. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. Biochem Biophys Res Commun 1999; 258: 395-400.
14. Elliott BE, Meens JA, SenGupta SK, Louvard D, Arpin M. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res 2005; 7: R365-R373.
15. Khanna C, Wan X, Bose S, Cassaday R, Olomu O, Mendoza A et al. The membranecytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 2004; 10: 182-186.
16. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004; 10: 175-181.
17. Monni R, Haddaoui L, Naba A, Gallais I, Arpin M, Mayeux P et al. Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia. Blood 2008; 111: 3163-3172.
18. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a deathinducing signaling complex (DISC) with the receptor. EMBO J 1995; 14: 5579-5588.
19. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675-1687.
20. Parlato S, Giammarioli AM, Logozzi M, Lozupone F, Matarrese P, Luciani F et al. CD95 (APO-1/Fas) linkage to the actin cytoskeleton through ezrin in human T lymphocytes: a novel regulatory mechanism of the CD95 apoptotic pathway. EMBO J 2000; 19: 5123-5134.
21. Hebert M, Potin S, Sebbagh M, Bertoglio J, Breard J, Hamelin J. Rho-ROCKdependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells. J Immunol 2008; 181: 5963-5973.
22. Chakrabandhu K, Herincs Z, Huault S, Dost B, Peng L, Conchonaud F et al. Palmitoylation is required for efficient Fas cell death signaling. EMBO J 2007; 26: 209-220.
23. Kuo WC, Yang KT, Hsieh SL, Lai MZ. Ezrin is a negative regulator of death receptorinduced apoptosis. Oncogene 2010; 29: 1374-1383.
24. Smertenko A, Franklin-Tong VE. Organisation and regulation of the cytoskeleton in plant programmed cell death. Cell Death Differ 2011; 18: 1263-1270.
25. Yonemura S, Matsui T, Tsukita S. Rho-dependent and -independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo. J Cell Sci 2002; 115: 2569-2580.
26. Riento K, Ridley AJ. Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 2003; 4: 446-456.
27. Chang J, Xie M, Shah VR, Schneider MD, Entman ML, Wei L et al. Activation of Rhoassociated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci USA 2006; 103: 14495-14500.
28. Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001; 3: 339-345.
29. Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol 2001; 3: 346-352.
30. Bretscher A. Purification of an 80,000-dalton protein that is a component of the isolated microvillus cytoskeleton, and its localization in nonmuscle cells. J Cell Biol 1983; 97: 425-432.
31. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: integrators at the cell cortex. Nat Rev Mol Cell Biol 2002; 3: 586-599.
32. Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M. Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 2003; 14: 2181-2191.
33. Pust S, Morrison H, Wehland J, Sechi AS, Herrlich P. Listeria monocytogenes exploits ERM protein functions to efficiently spread from cell to cell. EMBO J 2005; 24: 1287-1300.
34. Roumier A, Olivo-Marin JC, Arpin M, Michel F, Martin M, Mangeat P et al. The membrane-microfilament linker ezrin is involved in the formation of the immunological synapse and in T cell activation. Immunity 2001; 15: 715-728.
35. Ueda H, Morishita R, Itoh H, Narumiya S, Mikoshiba K, Kato K et al. Galpha11 induces caspase-mediated proteolytic activation of Rho-associated kinase, ROCK-I, in HeLa cells. J Biol Chem 2001; 276: 42527-42533.
36. Coudray AM, Louvet C, Kornprobst M, Raymond E, Andre T, Tournigand C et al. Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms. Int J Oncol 2005; 27: 553-561.
37. Morelli A, Chiozzi P, Chiesa A, Ferrari D, Sanz JM, Falzoni S et al. Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells. Mol Biol Cell 2003; 14: 2655-2664.
38. Rebillard A, Jouan-Lanhouet S, Jouan E, Legembre P, Pizon M, Sergent O et al. Cisplatin-induced apoptosis involves a Fas-ROCK-ezrin-dependent actin remodelling in human colon cancer cells. Eur J Cancer 2010; 46: 1445-1455.
39. Boratko A, Gergely P, Csortos C. Cell cycle dependent association of EBP50 with protein phosphatase 2A in endothelial cells. PLoS One 2012; 7: e5595.
40. Tanabe A, Shiraishi M, Negishi M, Saito N, Tanabe M, Sasaki Y. MARCKS dephosphorylation is involved in bradykinin-induced neurite outgrowth in neuroblastoma SH-SY5Y cells. J Cell Physiol 2012; 227: 618-629.
41. Wang X, Zhang F, Yang L, Mei Y, Long H, Zhang X et al. Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo. J Biomed Biotechnol 2011; 2011: 419343.
42. Yamai H, Sawada N, Yoshida T, Seike J, Takizawa H, Kenzaki K et al. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int J Cancer 2009; 125: 952-960.